Taipei, Taiwan

Chien-Jen Lin



 

Average Co-Inventor Count = 3.4

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2017-2021

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Chien-Jen Lin: Innovator in Pharmaceutical Constructs

Introduction

Chien-Jen Lin is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of molecular constructs aimed at treating various diseases. With a total of six patents to his name, Lin's work showcases his dedication to advancing medical science.

Latest Patents

Among his latest patents, Lin has developed pharmaceutical constructs with enhanced binding affinity with albumin. This innovation provides various molecular constructs that incorporate a plurality of fatty acids and a functional element. Additionally, he has created molecular constructs for treating tumors, which include a targeting element and an effector element. These constructs are designed to improve treatment methods for various diseases.

Career Highlights

Chien-Jen Lin has worked at Academia Sinica, a leading research institution in Taiwan. His role there has allowed him to engage in groundbreaking research and development in the pharmaceutical sector. His contributions have been instrumental in pushing the boundaries of what is possible in medical treatments.

Collaborations

Lin has collaborated with notable colleagues, including Tse-Wen Chang and Hsing-Mao Chu. These partnerships have fostered an environment of innovation and have led to the successful development of his patented technologies.

Conclusion

Chien-Jen Lin's work in pharmaceutical constructs exemplifies the impact of innovative thinking in medicine. His patents reflect a commitment to improving health outcomes through advanced research and collaboration. His contributions continue to influence the field and inspire future innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…